Electroacupuncture Regulates Cannabinoid Receptor 1 Expression in a Mouse Fibromyalgia Model: Pharmacological and Chemogenetic Modulation.

Fibromyalgia is a challenging chronic condition that causes widespread body pain, fatigue, anxiety, depression, and sleep problems. Despite its prevalence, doctors don't fully understand what causes it, making treatment difficult for many patients. Researchers recently studied how electroacupuncture—a technique that adds mild electrical stimulation to traditional acupuncture needles—might help relieve fibromyalgia pain in mice.

The research team created a fibromyalgia-like condition in mice using intermittent cold stress, which produced pain sensitivity similar to what human patients experience. They discovered that electroacupuncture treatment significantly reduced both mechanical and heat-related pain responses in these mice. The key breakthrough was identifying that electroacupuncture works by increasing levels of a specific protein called cannabinoid receptor 1 (CB1) in several brain regions involved in pain processing, including the thalamus, somatosensory cortex, and anterior cingulate cortex.

When researchers blocked CB1 receptors, the pain-relieving effects of electroacupuncture disappeared, confirming this protein's essential role. Conversely, when they activated CB1 receptors with medication, pain levels decreased even without electroacupuncture. The study also found that electroacupuncture reduced levels of pain-related proteins and inflammatory markers in the brain.

For fibromyalgia patients, these findings suggest electroacupuncture may offer genuine pain relief by targeting specific biological pathways in the brain's pain centers. While this was an animal study and human trials are needed, it provides scientific evidence for how acupuncture might help manage fibromyalgia symptoms. If you're considering electroacupuncture for fibromyalgia, consult with a licensed acupuncturist who has experience treating chronic pain conditions.

This preclinical study investigated cannabinoid receptor 1 (CB1) signaling mechanisms underlying electroacupuncture analgesia in a mouse fibromyalgia model induced by intermittent cold stress (ICS). Mice exhibited mechanical hyperalgesia (2.09 ± 0.09 g von Frey threshold) and thermal hyperalgesia (4.77 ± 0.29 s Hargraves' test). Electroacupuncture treatment significantly ameliorated pain behaviors while sham EA showed no effect. Western blot analysis revealed ICS-induced CB1 downregulation in the thalamus, somatosensory cortex (SSC), and anterior cingulate cortex, with concurrent elevation of pain-related protein kinases and transcription factors. EA reliably upregulated CB1 expression across these pain-processing regions and reduced nociceptive mediators. Pharmacological validation demonstrated CB1 agonist administration attenuated fibromyalgia pain, while CB1 antagonism reversed EA analgesia. Chemogenetic SSC inhibition further confirmed regional specificity. These findings establish CB1 signaling as a critical mechanism of EA-mediated analgesia in fibromyalgia, supporting its clinical application and identifying CB1 as a potential therapeutic target for fibromyalgia management.